Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

How to Analyze and Leverage the Value of Tech IP

Related Content

FTC Issues Final Rule Prohibiting Most Post-Employment Non-Compete Agreements

FinCEN Proposed the Renewal of its Existing Information Collection Requirements Previously Promulgated Under the BSA

European Commission’s First-Ever Abuse of Dominance Probe for Shelving of a Novel Pipeline Therapy

Healthcare M&A and Financing Trends and Predictions for 2024

Delaware Supreme Court Holds That Boards Must Satisfy the MFW Framework in Controller Transactions to Obtain Business Judgment Deference (Westlaw Today)

CFPB Updates Supervision Designation Procedures

Delaware Supreme Court Holds That Boards Must Satisfy the MFW Framework in Controller Transactions to Obtain Business Judgment Deference

OCC Extends Comment Period for Proposed Rulemaking and Policy Statement on Bank Mergers

What Tech Companies Need to Know: State of Tech M&A Panel

Townsend Holdings Sold to Riverside

Deciphera Pharmaceuticals To Be Acquired By ONO Pharmaceutical For $2.4 Billion

Digital Markets Guide: US Skepticism of Tech Transactions Sparks a Step-Up in Merger Enforcement (GCR)

Alpine Immune Sciences To Be Acquired by Vertex Pharmaceuticals For $4.9 Billion

Auradine Raises $80 Million in Series B Financing and Achieves $80 Million in Bookings

Deal Watch: M&A (Law.com)

US Law Firms Ride Rising M&A Wave in Q1 (Reuters)

Technology

Mergers & Acquisitions

Data, Privacy & Cybersecurity

Strategic Technology Transactions and Licensing

Patent Prosecution & Counseling

Patent Litigation

Trademarks